PROVECTUS BIOPHARMACEUTICALS, INC. Quarterly Return On Equity in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Provectus Biopharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2012 to Q2 2024.
  • Provectus Biopharmaceuticals, Inc. Return On Equity for the quarter ending June 30, 2024 was 37.1 %, a 18.3% decline year-over-year.
  • Provectus Biopharmaceuticals, Inc. annual Return On Equity for 2023 was 42.2 %, a 27.9% decline from 2022.
  • Provectus Biopharmaceuticals, Inc. annual Return On Equity for 2022 was 58.5 %, a 9.22% increase from 2021.
  • Provectus Biopharmaceuticals, Inc. annual Return On Equity for 2021 was 53.6 %, a 125% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 37.1 -8.29 -18.3% Apr 1, 2024 Jun 30, 2024
Q1 2024 37.2 -13.9 -27.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 42.2 -16.3 -27.9% Oct 1, 2023 Dec 31, 2023
Q3 2023 45.2 -27.7 -38% Jul 1, 2023 Sep 30, 2023
Q2 2023 45.4 -50.5 -52.6% Apr 1, 2023 Jun 30, 2023
Q1 2023 51.1 -81.2 -61.4% Jan 1, 2023 Mar 31, 2023
Q4 2022 58.5 +4.94 +9.22% Oct 1, 2022 Dec 31, 2022
Q3 2022 73 +37.5 +106% Jul 1, 2022 Sep 30, 2022
Q2 2022 95.9 +68 +244% Apr 1, 2022 Jun 30, 2022
Q1 2022 132 +110 +499% Jan 1, 2022 Mar 31, 2022
Q4 2021 53.6 +29.8 +125% Oct 1, 2021 Dec 31, 2021
Q3 2021 35.5 +10.7 +43.3% Jul 1, 2021 Sep 30, 2021
Q2 2021 27.9 +0.58 +2.13% Apr 1, 2021 Jun 30, 2021
Q1 2021 22.1 -9.47 -30% Jan 1, 2021 Mar 31, 2021
Q4 2020 23.8 -8.25 -25.8% Oct 1, 2020 Dec 31, 2020
Q3 2020 24.7 -13.2 -34.7% Jul 1, 2020 Sep 30, 2020
Q2 2020 27.3 -13.3 -32.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 31.6 -9.05 -22.3% Jan 1, 2020 Mar 31, 2020
Q4 2019 32 -23.3 -42.1% Oct 1, 2019 Dec 31, 2019
Q3 2019 37.9 -29.6 -43.8% Jul 1, 2019 Sep 30, 2019
Q2 2019 40.5 -53.1 -56.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 40.6 -101 -71.3% Jan 1, 2019 Mar 31, 2019
Q4 2018 55.4 -185 -77% Oct 1, 2018 Dec 31, 2018
Q3 2018 67.5 -637 -90.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 93.6 +2.13K Apr 1, 2018 Jun 30, 2018
Q1 2018 141 +619 Jan 1, 2018 Mar 31, 2018
Q4 2017 241 +545 Oct 1, 2017 Dec 31, 2017
Q3 2017 704 +963 Jul 1, 2017 Sep 30, 2017
Q2 2017 -2.04K -1.86K -1028% Apr 1, 2017 Jun 30, 2017
Q1 2017 -478 -344 -258% Jan 1, 2017 Mar 31, 2017
Q4 2016 -304 -199 -188% Oct 1, 2016 Dec 31, 2016
Q3 2016 -259 -204 -369% Jul 1, 2016 Sep 30, 2016
Q2 2016 -181 -131 -264% Apr 1, 2016 Jun 30, 2016
Q1 2016 -134 -96.1 -256% Jan 1, 2016 Mar 31, 2016
Q4 2015 -106 -53.9 -104% Oct 1, 2015 Dec 31, 2015
Q3 2015 -55.2 +127 +69.7% Jul 1, 2015 Sep 30, 2015
Q2 2015 -49.7 +179 +78.3% Apr 1, 2015 Jun 30, 2015
Q1 2015 -37.5 +296 +88.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -51.7 +356 +87.3% Oct 1, 2014 Dec 31, 2014
Q3 2014 -182 +26.7 +12.8% Jul 1, 2014 Sep 30, 2014
Q2 2014 -228 -7.87 -3.57% Apr 1, 2014 Jun 30, 2014
Q1 2014 -333 -62.9 -23.2% Jan 1, 2014 Mar 31, 2014
Q4 2013 -408 -142 -53.1% Oct 1, 2013 Dec 31, 2013
Q3 2013 -209 +21.2 +9.22% Jul 1, 2013 Sep 30, 2013
Q2 2013 -221 -1.51 -0.69% Apr 1, 2013 Jun 30, 2013
Q1 2013 -271 -95.4 -54.5% Jan 1, 2013 Mar 31, 2013
Q4 2012 -266 Oct 1, 2012 Dec 31, 2012
Q3 2012 -230 Jul 1, 2012 Sep 30, 2012
Q2 2012 -219 Apr 1, 2012 Jun 30, 2012
Q1 2012 -175 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.